Skip to main content
Annals of Clinical Microbiology and Antimicrobials logoLink to Annals of Clinical Microbiology and Antimicrobials
. 2023 Apr 18;22:26. doi: 10.1186/s12941-023-00578-y

Correction: Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope

Rawan Taha 1, Ola Kader 1, Sherine Shawky 1, Shahinda Rezk 2,
PMCID: PMC10114405  PMID: 37072825

Correction: Ann Clin Microbiol Antimicrob (2023) 22:21

10.1186/s12941-023-00573-3

Following publication of the original article [1], the author noticed the errors in the affiliation details. The first author, “Rawan Taha” should be affiliated only in “Microbiology Department, Medical Research Institute, Alexandria University, Egypt”. The right affliations for the authors should be as follows.

Rawan Taha (1)

Ola Kader (1)

Sherine Shawky (1)

Shahinda Rezk (2)

1: Microbiology Department, Medical Research Institute, Alexandria University, Egypt.

2: Lecturer of Molecular and Diagnostic Microbiology, Microbiology Department, Medical Research Institute, Alexandria University, 165 Horreya Avenue, Hadara, Alexandria, Egypt.

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s12941-023-00573-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Taha R, Kader O, Shawky S, et al. Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope. Ann Clin Microbiol Antimicrob. 2023;22:21. doi: 10.1186/s12941-023-00573-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Clinical Microbiology and Antimicrobials are provided here courtesy of BMC

RESOURCES